Hit Finding

Combined approaches to identify innovative starting points

Target-dependent methods, using a combination of biophysical techniques, chemoinformatics and medicinal chemistry with versatile screening platforms, are used to find promising hits.

  • A priori Selection: 
    A priori selection of molecules based on publications, virtual screening (structure-based drug design, ligand-based drug design) and medicinal chemistry knowledge, followed by binding confirmation.
  • Fragment Screening
    The NovA-Frag library of 1000 fragments can be screened on different biophysical platforms such as NMR or native MS. Hits can be confirmed by an orthogonal assay.

Do you want to learn more?

Contact us to get business support or discussion with an expert.

This website uses cookies to improve user experience